Diagnostic and therapeutic challenges in claudin 18.2-positive gastric cancer treated with zolbetuximab: Intrapatient heterogeneity or secondary loss of expression?
- DOI
- 10.1007/s00432-026-06447-3
- Published
- 2026-03-19
- Container
- Journal of Cancer Research and Clinical Oncology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s00432-026-06447-3,
title = {Diagnostic and therapeutic challenges in claudin 18.2-positive gastric cancer treated with zolbetuximab: Intrapatient heterogeneity or secondary loss of expression?},
author = {O. Morath and U. Lindig and K. Katenkamp and N. Gassler and D. Haziri and V. Auletta and D. Bauerschlag and T. Franiel and M. Bergener and A. S. Griessbach and T. Ernst and A. Hochhaus and C. C. Crodel},
year = {2026},
journal = {Journal of Cancer Research and Clinical Oncology},
doi = {10.1007/s00432-026-06447-3},
url = {https://doi.org/10.1007/s00432-026-06447-3}
}RIS
TY - JOUR TI - Diagnostic and therapeutic challenges in claudin 18.2-positive gastric cancer treated with zolbetuximab: Intrapatient heterogeneity or secondary loss of expression? AU - O. Morath AU - U. Lindig AU - K. Katenkamp AU - N. Gassler AU - D. Haziri AU - V. Auletta AU - D. Bauerschlag AU - T. Franiel AU - M. Bergener AU - A. S. Griessbach AU - T. Ernst AU - A. Hochhaus AU - C. C. Crodel PY - 2026 JO - Journal of Cancer Research and Clinical Oncology DO - 10.1007/s00432-026-06447-3 UR - https://doi.org/10.1007/s00432-026-06447-3 ER -
APA
Morath, O., Lindig, U., Katenkamp, K., Gassler, N., Haziri, D., Auletta, V., Bauerschlag, D., Franiel, T., Bergener, M., Griessbach, A. S., Ernst, T., Hochhaus, A., & Crodel, C. C. (2026). Diagnostic and therapeutic challenges in claudin 18.2-positive gastric cancer treated with zolbetuximab: Intrapatient heterogeneity or secondary loss of expression?. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-026-06447-3
Source records
- crossref · retrieved 2026-09-26T13:11:08.170Z